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Summary. Introduction. Nowadays there are a number of questionnaires with a score 
assessment of mental disorders. However, they are not adapted to the specific manifestations 
of DRP and require additional correction.  
Aim. To determine the criteria of necessity of psychological help for the patient with 
DRP.  
Materials and methods. 96 patients with DRP. The methods of the study were as 
follows: functional diagnostic examinations (visometry without correction and with optimal 
correction, direct and indirect ophthalmoscopy, optical coherent tomography of the retina and 
the optic disc); the assessment of mental state of patients using original and adapted tests.  
Results. The criteria of necessity of specialized psychological help for the patient with 
DRP are: level of fatigue manifestations in points is higher than 33 for patients with NPDRP, 
49 with PPDRP and 56 with PDRP (according to the mean values of the total score of MFI at 
the corresponding stage of DRP); veracity of at least 2 statements from the additional 
questions and/or high values (>12) of at least 2 MFI subscales; changes in cognitive function, 
classified as severe or moderate.  
Conclusions. The integrated, modified questionnaire for patient's mental condition 
assessment, based on MFI for fatigue manifestations, MMSE for cognitive impairment and 
the additional questions provides a reliable way to determine the criteria for specialized 
psychological help necessity. 
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Introduction. Diabetic retinopathy (DRP) is a widespread and threatening problem. 
Of all registered cases of diabetes mellitus (DM) (366 million in 2011 with an estimated 
growth to 552 million in 2030 [1]) it develops in 30-60% [2]. After 10 years of the disease, 
most patients with DM have manifestations of DRP [3, 4]. DRP is a disruption of the retina 
functions, which leads to blindness and simultaneously to severe psychological complications 
in the patient due to progressive reduction of vision with a combination of diabetic 
encephalopathy signs. The clinical picture of diabetic encephalopathy is manifold, it is a 
pattern of cognitive impairments such as reduced memory and attention, worsening of 
orientation in time and space, decreased mental and physical capacity, sleep disturbance, 
emotional lability or depression, autonomic neurological disorders [5]. Similarly, any 
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disruption of the visual function can be associated with a number of social and emotional 
complications [6, 7]. Up to 1/3 of people with various visual impairments have significant 
depressive manifestations [7]. Working adult population with vision impairments of any 
genesis often report general decrease in mental health, socialization and a lower quality of life 
compared to their healthy peers [8]. With DRP, this reduction in vision is progressive and 
more pronounced. Mental discomfort is also caused by the specificity of DRP treatment: 
vitrectomy, intravitreal administration of drugs, a large amount of laser coagulation. The 
patient is afraid of the procedures and their complications, often doubts their effectiveness and 
is significantly frustrated after the smallest treatment failures. Also, the financial burden is a 
considerable problem due to the high cost of ophthalmic interventions. The combination of 
such mental complications with the progression of DRP and, consequently, steady loss of 
vision, contributes to the formation of a vicious circle, reducing the motivation to treatment 
and its effectiveness through all of the above mentioned problems [9]. Today professional 
psychological examination of patients in ophthalmology departments and hospitals is not 
provided, therefore it is important for ophthalmologists be able to singly and quickly assess 
the emotional and cognitive disturbances to determine whether a psychotherapist is required. 
With a timely detection of such manifestations and adequate elimination of them, it is 
possible to significantly improve the quality of life of the patient with DRP, to motivate for 
the necessary medical procedures, which will positively affect the outcome of treatment. 
Nowadays there are a number of questionnaires with a score assessment of mental 
disorders. However, they are not adapted to the specific manifestations of DRP and require 
additional correction. All this determines the relevance of the problem of timely diagnosis of 
psychological disorders in patients with DRP. 
Aim. To determine the criteria of necessity of psychological help for the patient with 
DRP. 
Materials and methods. On the basis of the Department of Otorhinolaryngology with 
Ophthalmology of the Ukrainian Medical Stomatological Academy and the Ophthalmology 
Department of the Poltava Regional Clinical Hospital named after M.V. Sklifosovsky 96 
patients with DRP at different stages of development were examined, and were divided into 
three groups of observation.The study was conducted in compliance with ethical norms, and 
the norms of the Helsinki Declaration. All respondents filled out an informed consent to 
participate in the study.The age of patients was from 43 to 67 years (56±0.7 years on 
average), there were 57 men and 39 women.The methods of the study were as follows: 
functional diagnostic examinations (visometry without correction and with optimal 
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correction, direct and indirect ophthalmoscopy, optical coherent tomography of the retina and 
the optic disc); the assessment of mental state of patients using original and adapted tests. 
The assessment of visual acuity was conducted in a well-lit room, from a distance of 5 
meters, using the EDTRS tables with Ukrainian optotypes (patent for utility model №117908 
dated 10.07.2017) according to modified ETDRS tables №1, №2 (copyrights №73733, 
№73742 respectively). Indirect ophthalmoscopy was performed in a darkened room using the 
ophthalmoscope OZ-5. The examiner was at a distance of 40-50 cm from the patient, in the 
right arm took an ophthalmoscopic mirror, and in the left – a 13 D lens. The mirror was 
placed to the patient’s eye, directing the reflected beams from the light source located behind 
and somewhat to the left from the patient, to the pupil of the examined eye, viewing it through 
the hole of the ophthalmoscopic mirror. After an even glow of the pupil is recieved, the 
examiner placed a magnifying glass at a distance of 7-8 cm from the eye (ophthalmoscope 
opening, center of loupe and the pupil should have been on one axis). Accommodating to the 
frontal plane, which is located in 5-8 cm from the loupe, the investigator could see as if in the 
air a true reverse and enlarged image of the fundus (in order to improve the observation, the 
pupil of the examined eye was dilated with mydriatics). For a detailed examination of the eye 
fundus, a direct ophthalmoscopy with an electric hand-held ophthalmoscope HEINE mini 
3000 was performed, also in a darkened room. The researcher pressed the device tightly to 
their eye and approached the eye of the patient (to a distance of 2-3 cm), directing a beam of 
light through the dilated pupil. After the image of the fundus appeared, a lens was adjusted by 
turning a large refractive disc, correcting the ametropia of the investidator and the patient to 
obtain a clear image. For ophthalmoscopy in a red-free light, a blue-green filter was 
introduced into the optical system by rotating the disk. Optical coherent tomography (OCT) 
of the retina and the optic nerve disk (Fig.1) was performed on the TOPCON 3D OCT-2000 
Series device, mapping in the «Macula: 3D Scan» mode of 512x128, 6x6 mm. To analyse and 
measure the structure of the retina, the following reflections of the retina layers were used: 
- the vitreoretinal interface, 
- the nerve fibres layer, 
- the ganglionic layer, 
- the inner and the outer nuclear layers, 
- the inner and outer plexiform layers, 
- membrana limitans externa, 
- the layer of rods and cones; 
- the neuroepithelium, 
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- the pigmented layer and the layer of choriocapillaries. 
For the assessment of mental disorders we used the Multidimensional Fatigue 
Inventory (MFI, E.M. Smets et al., 1995) and the Mini-Mental State Examination (MMSE, 
M.F. Folstein et al., 1975). The Multidimensional Fatigue Inventory (MFI) by E.M. Smets, B. 
Garssen, B. Bonke, J. De Haes, 1995 includes 20 questions. 
A patient evaluates their condition and grades each statement according to its 
truthfulness with a 5-point scale. 
1. I feel fit. 
Yes, that is true 1   2   3   4   5 No, that is not true 
2. Physically I feel only able to do a little. 
Yes, that is true 5   4   3   2   1 No, that is not true 
3. I feel very active. 
Yes, that is true 1   2   3   4   5 No, that is not true 
4. I feel like doing all sorts of nice things. 
Yes, that is true 1   2   3   4   5 No, that is not true 
5. I feel tired. 
Yes, that is true 5   4   3   2   1 No, that is not true 
6. I think I do a lot in a day. 
Yes, that is true 1   2   3   4   5 No, that is not true 
7. When I am doing something, I can keep my thoughts on it. 
Yes, that is true 1   2   3   4   5 No, that is not true 
8. Physically I can take on a lot. 
Yes, that is true 1   2   3   4   5 No, that is not true 
9. I dread having to do things. 
Yes, that is true 5   4   3   2   1 No, that is not true 
10. I think I do very little in a day. 
Yes, that is true 5   4   3   2   1 No, that is not true 
11. I can concentrate well. 
Yes, that is true 1   2   3   4   5 No, that is not true 
12. I am rested. 
Yes, that is true 1   2   3   4   5 No, that is not true 
13. It takes a lot of effort to concentrate on things. 
Yes, that is true 5   4   3   2   1 No, that is not true 
14. Physically I feel I am in a bad condition. 
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Yes, that is true 5   4   3   2   1 No, that is not true 
15. I have a lot of plans. 
Yes, that is true 1   2   3   4   5 No, that is not true 
16. I tire easily. 
Yes, that is true 5   4   3   2   1 No, that is not true 
17. I get little done. 
Yes, that is true 5   4   3   2   1 No, that is not true 
18. I don’t feel like doing anything. 
Yes, that is true 5   4   3   2   1 No, that is not true 
19. My thoughts easily wander. 
Yes, that is true 5   4   3   2   1 No, that is not true 
20. Physically I feel I am in an excellent condition. 
Yes, that is true 1   2   3   4   5 No, that is not true (Table І) 
Mini-Mental State Examination (MMSE), M.F. Folstein, S.E. Folstein, P.R. McHugh, 1975. 
The patient must complete the task or answer the questions. 
1. “What is the year (1 point)? Season (1)? Month (1)? Date (1)? Day of the week (1)?”  
2. “Where are we now: Region (1)? County (1)? Town/city (1)? Hospital (1)? Floor (1)?” 
3. The examiner names three unrelated objects clearly and slowly, then asks the patient to 
name all three of them (like ball, man, car; flower, dog, table etc). 3 points. 
4. “Spell WORLD backwards.” 5 points. 
5. “Earlier I told you the names of three things. Can you tell me what those were?” 3 points. 
6. Show the patient two simple objects, such as a wristwatch and a pencil, and ask the patient 
to name them. 2 points. 
7. “Repeat the phrase: ‘No ifs, ands, or buts.’”. 1 point. 
8. “Take the paper in your right hand, fold it in half, and put it on the floor.” (The examiner 
gives the patient a piece of blank paper.) 3 points. 
9. “Please read this and do what it says.” (Written instruction is “Close your eyes.”) 1 point.  
10. “Make up and write a sentence about anything.” (This sentence must contain a noun and a 
verb.) 1 point. 
11. “Please copy this picture.” (The examiner gives the patient a blank piece of paper and asks 
him/her to draw the symbol below. All 10 angles must be present and two must intersect (Fig. 
1)).  
Results: 
24-30 points – No cognitive impairment; 
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22-23 – Minor cognitive impairment (conditionally absent if the individual has only a general 
secondary education); 
18-21 – Mild or moderate cognitive impairment; 
0-17 – Severe cognitive impairment. 
The tests were combined during the patients’ examination. We conducted the MFI 
orally because of the decrease in visual acuity in most patients. Furthermore, to increase the 
sensitivity of the study, the following additional questions were used (randomly asked during 
the examination), or similar phrases were tracked in patients’ statements: 
My doctor does not pay enough attention to my suffering. 
Yes, that is true   I do not know   No, that is not true 
My treatment is too complicated and uncomfortable. 
Yes, that is true   I do not know   No, that is not true 
My vision can not be saved 
Yes, that is true   I do not know   No, that is not true 
I do not have to worry about my health at all 
Yes, that is true   I do not know   No, that is not true 
I am sure that treatment will not be beneficial 
Yes, that is true   I do not know   No, that is not true 
I do not trust my doctor 
Yes, that is true   I do not know   No, that is not true 
My finances are not enough for minimal treatment 
Yes, that is true   I do not know   No, that is not true 
We have also modified several MMSE questions: 
№ 6: Show the patient one simple object, such as a wristwatch, a pencil, a paper, or a pen, and 
ask the patient to name it. 1 point. 
№ 9: If a patient has problem with reading, the examiner closes their eyes and asks to repeat 
after them. 
№ 10: If a patient has problem with writing, the sentence could be spoken aloud. 
№ 11: We asked a patient to divide a large square, which is already depicted on paper (or 
imaginary, if necessary, but then without a point in the centre), on nine small identical squares 
by drawing four straight lines and to put a dot in the centre. 2 points. 
Modified question number 11 evaluates simultaneously the presence of 
metamorphopsia in a patient with DRP and the ability to estimate the geometry of the figure 
only by the examiner’s instructions. 
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Statistical analysis of the results is done using descriptive statistics of the EXEL 
software. The arithmetic mean value (M), standard error of mean (mM), the probability value 
(p), the determination coefficient (R2), the Pearson correlation coefficient (r) were calculated. 
The probability value in the work is taken as р<0,05. 
Results. In our country the most up-to-date DRP classification is the one proposed by 
Pasechnikova N.V. and Naumenko V.O., which was approved at the XII Congress of 
Ophthalmologists of Ukraine (Odessa, 2010) (Table IІ). We used this classification to analyse 
the changes in the eye fundus of the examined patients. 
Nonproliferative DRP (NPDRP) – group І (Fig.2, a) 
Patients with this stage did not have complaints on vision. However, on ophthalmoscopy, the 
following changes were observed: burciform protuberances of the capillaries 
(microaneurysms) – 30 patients (60 eyes, 100%), intraretinal punctate or dashed 
haemorrhages – 23 patients (39 eyes, 65%), intraretinal microvascular anomalies (shunts 
between arterioles and venules) – 12 patients (18 eyes, 30%), solid exudates – 18 patients (30 
eyes, 50%). 
Pre-proliferative DRP (PPDRP) – group ІІ (Fig.2, b) 
For 31 patients (62 eyes) this stage was characterized by: accumulated haemorrhages in 28 
patients (56 eyes, 90.3%), diffuse retinal oedema in 13 patients (20 eyes, 32.3%), venous loop 
formation in 25 patients (43 eyes, 69.4%), as well as ischemic areas of the retina – 8 patients 
(16 eyes, 25.8%). The veins of the retina were beaded, unevenly enlarged in 31 patients (62 
eyes, 100%).  
Proliferative DRP (PDRP) – group ІІІ (Fig.2, c) 
On the eye fundus 35 patients (70 eyes, 100%) had zones of ischemia with 
neovascularization, oedema of the retina, fibrous changes of the posterior hyaloid mebrane; 
preretinal haemorrhages were observed in 15 patients (28 eyes, 40%), hemophthalmus in 11 
patients (11 eyes, 15.7%), tractional detachment of retina in 7 patients (9 eyes, 12.9%). 
The results of visometry by ETDRS tables were as follows: in patients of the group I – 
0.72±0.14, of the group II – 0.34 ± 0.02, in the group III – 0.09 ± 0.005. 
Patients were interviewed using a modified mental test. Duration of mental state 
examination of one person was 15-17 minutes. Due to the combined application of the tests 
and their modifications, we were able to adapt them to the characteristics of patients with 
DRP. 
A correlation analysis was performed with the severity of fatigue and cognitive 
manifestations compared to the stages of DRP.  
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We studied the dependence of the aggravation of fatigue manifestations, which we 
evaluated in points (Y) from the stage of DRP, which was determined clinically (X). To test 
the hypothesis, all the obtained data was processed statistically. On the basis of these findings, 
correlation fields (Fig.3) were constructed and the regression equation was chosen to estimate 
the relationships between the above described parameters. Thus, there is a direct strong 
correlation between the increase in fatigue manifestation (total score) and the stage of DRP. 
The determination coefficient (R2) is 0,73; the correlation coefficient (r) is 0,66 (p<0,05).  
We also noted the increase in mean values of the MFI subscales by the stages of DRP 
(Fig.4). Furthermore, the answers “yes, this is true” to additional questions or the presence of 
similar personal phrases in the amount of at least 2 coincide with no less than 2 values of the 
MFI subscales above 12 points. 
At the same time, we studied the dependence of cognitive impairment severity, which 
was evaluated in points (Y) from the stage of DRP, which was determined clinically (X). To 
test the hypothesis, all the obtained data was processed statistically, the sampling is indicated 
in Table IIІ. On the basis of these findings, correlation fields (Fig.5) were constructed and the 
regression equation was chosen to estimate the relationships between the above described 
investigated parameters. Thus, there is a tendency, but a low correlation between the decrease 
of cognitive function and the DRP stage. The determination coefficient (R2) is 0,23; the 
correlation coefficient (r) is -0,17.  
Based on the obtained data we have formulated the criteria of necessity of specialized 
psychological help for the patient with DRP. 
At least one of the following may be a criterion: 
- The level of fatigue manifestations in points is higher than 33 for patients with 
NPDRP, 49 with PPDRP and 56 with PDRP (according to the mean values of the 
total score of MFI at the corresponding stage of DRP). 
- Veracity of at least 2 statements from the additional questions and/or high values 
(>12) of at least 2 MFI subscales. 
- Changes in cognitive function, classified as severe or moderate. 
Conclusions. 
1. The integrated, modified questionnaire for patient's mental condition assessment, 
based on MFI for fatigue manifestations, MMSE for cognitive impairment and the 
additional questions provides a reliable way to determine the criteria for specialized 
psychological help necessity. 
2. A modified test is adapted to the features of patients with diabetic retinopathy.  
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3. A strong correlation was found between the severity of fatigue manifestations and the 
stage of diabetic retinopathy, the result is reliable (the determination coefficient is 
0,73; the correlation coefficient is 0,66, p<0,05). A tendency with a low correlation 
between the decrease in cognitive function and the stage of DRP was found (the 
determination coefficient is 0,23; the correlation coefficient is -0,17). 
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Fig. 1. 1 point 
Fig. 2. Nonproliferative (a), Pre-proliferative (b) and Proliferative (c), DRP on OCT. 
Fig. 3. Dependence of increase in fatigue manifestations (total score) from the stage of DRP. 
Fig. 4. Evaluation of fatigue manifestations in patients with different stages of DRP by mean 
values of MFI subscales. 
Fig. 5. Dependence of decrease in cognitive function from the stage of DRP. 
Table I. Results 
Table IІ. The DRP classification, approved at the XII Congress of Ophthalmologists of 
Ukraine. 
Table IIІ. Evaluation of cognitive impairment in patients with different stages of DRP. 
